|
Volumn 13, Issue 3, 1995, Pages 129-134
|
Overlapping substrate specificities and tissue distribution of cytochrome p450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
a a a |
Author keywords
Countertransport; Metabolism; Multidrug resistance
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTIFUNGAL AGENT;
ANTINEOPLASTIC AGENT;
CALCIUM ANTAGONIST;
CYCLOSPORIN A;
CYTOCHROME P450 3A;
DILTIAZEM;
DOXORUBICIN;
ETOPOSIDE;
FELODIPINE;
FLAVONOID;
GLYCOPROTEIN P;
HORMONE;
HYDROCORTISONE;
ITRACONAZOLE;
KETOCONAZOLE;
LIDOCAINE;
NICARDIPINE;
NIFEDIPINE;
NITRENDIPINE;
PACLITAXEL;
PROGESTERONE;
QUINIDINE;
TESTOSTERONE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VERAPAMIL;
VINBLASTINE;
VINCRISTINE;
VINDESINE;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG METABOLISM;
HUMAN;
META ANALYSIS;
MULTIDRUG RESISTANCE;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC AGENTS;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG RESISTANCE, MULTIPLE;
EPOXIDE HYDROLASES;
GENE EXPRESSION;
GLUTATHIONE TRANSFERASE;
HUMAN;
LIVER;
NEOPLASMS;
OXIDOREDUCTASES, N-DEMETHYLATING;
P-GLYCOPROTEIN;
SUBSTRATE SPECIFICITY;
SUPPORT, U.S. GOV'T, P.H.S.;
TISSUE DISTRIBUTION;
STAPHYLOCOCCUS PHAGE 3A;
|
EID: 0029028792
PISSN: 08991987
EISSN: None
Source Type: Journal
DOI: 10.1002/mc.2940130302 Document Type: Review |
Times cited : (842)
|
References (0)
|